Galectin ‑9 suppresses the tumor growth of colon cancer < em > in  vitro < /em > and < em > in  vivo < /em >

In conclusion, Gal‑9 suppresses the cell proliferation of human colon cancer by inducing apoptosis, and these findings suggest that Gal‑9 can be a potential therapeutic target in the treatment of colon cancer.PMID:33907832 | PMC:PMC8072828 | DOI:10.3892/or.2021.8056
Source: Oncology Reports - Category: Cancer & Oncology Authors: Source Type: research